Strides Pharma Science
STARNSE

Strides Pharma Science

₹1,000.003.75 (0.38%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
995.90
Today’s high
1,010.90
52 week low
596.85
52 week high
1,025.00
Open price
996.25
Previous close
996.25
Live volume
2,10,769
Lower circuit
800.00
Upper circuit
1,200.00

Fundamentals

Market Cap
₹9,223Cr
ROE
14.42%
P/E Ratio(TTM)
17.38
EPS(TTM)
57.59
P/B Ratio
3.35
Dividend Yield
0.40%
Industry P/E
31.77
Book Value
298.99
Debt to Equity
0.67
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Strides is a global pharmaceutical company that makes high-quality, affordable generic medicines for markets across the world. The company's vision is to become a leading Indian multinational pharmaceutical firm known for its superior quality and integrity. Its operations have a significant global footprint, reaching healthcare systems in over 100 countries worldwide.;
MD/CEO
Mr. Arun Pillai
Founded in
--
NSE symbol
STAR
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Retail And Others
29.58%
Foreign Institutions
29.54%
Promoters
27.86%
Mutual Funds
8.59%
Other Domestic Institutions
4.43%

Mutual Funds Invested (3)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Natco PharmaNATCOPHARM
₹1,104.20
-19.50 (1.74%)
L
    H
    19,771.9412.712.29
    ₹1,371.40
    +7.30 (0.54%)
    L
      H
      18,984.5340.335.4
      ₹631.95
      -3.55 (0.56%)
      L
        H
        15,658.2928.713.66
        ₹890.80
        +11.80 (1.34%)
        L
          H
          14,205.5833.082.16
          Livesquawk
          Strides Pharma to acquire Sandoz's generic brands in Africa for $12M. Deal finalization expected by Q2 FY27, subject to regulatory approvals.
          Livesquawk
          Strides Pharma Q3 net profit rises to ₹2B from ₹880M YoY.
          2026
          30
          Jan
          Quarterly Result
          Release date
          2025
          31
          Oct
          Quarterly Result
          Release date
          29
          Jul
          Quarterly Result
          Release date

          22
          Jul
          Dividend
          Ex date
          ₹4.00
          per share

          For each share you hold, you will receive ₹4.00
          Dividend amount₹4.00 per share
          Dividend TypeFinal
          Ex Date22 Jul ‘25
          Record Date22 Jul ‘25
          Announcement date22 May ‘25

          22
          May
          Dividend
          Announced
          ₹4.00
          per share

          For each share you hold, you will receive ₹4.00
          Dividend amount₹4.00 per share
          Dividend TypeFinal
          Ex Date22 Jul ‘25
          Record Date22 Jul ‘25
          Announcement date22 May ‘25
          2024

          6
          Dec
          Demerger into OneSource Specialty Pharma Ltd
          Ex date

          Demerger into OneSource Specialty Pharma Ltd. For every 2 shares you hold of the parent company undergoing demerger, you will receive 1 shares in the new demerged company.
          Ex date6 Dec ‘24
          Record date6 Dec ‘24
          Announcement date25 Sep ‘23
          Ratio2:1

          9
          Sep
          Dividend
          Ex date
          ₹2.50
          per share

          For each share you hold, you will receive ₹2.50
          Dividend amount₹2.50 per share
          Dividend TypeFinal
          Ex Date9 Sep ‘24
          Record Date9 Sep ‘24
          Announcement date22 May ‘24

          22
          May
          Dividend
          Announced
          ₹2.50
          per share

          For each share you hold, you will receive ₹2.50
          Dividend amount₹2.50 per share
          Dividend TypeFinal
          Ex Date9 Sep ‘24
          Record Date9 Sep ‘24
          Announcement date22 May ‘24
          Events calendar
          View upcoming events in other stocks